TriReme Medical
About:
TriReme Medical develops novel stent technologies for the treatment of coronary artery bifurcations.
Website: http://www.trirememedical.com
Top Investors: Adams Street Partners, EDBI, Three Arch Partners, Luminor Capital
Description:
TriReme Medical, Inc. (TMI) is a privately held medical device company based in Pleasanton, California. Founded in 2005, it is dedicated to the development and manufacturing of novel stent technologies for the treatment of coronary artery disease (CAD) at or near bifurcations.
Total Funding Amount:
$58.9M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Pleasanton, California, United States
Founded Date:
2005-01-01
Contact Email:
info(AT)TriRemeMedical.com
Founders:
Eitan Konstantino
Number of Employees:
51-100
Last Funding Date:
2012-11-27
IPO Status:
Private
Industries:
© 2025 bioDAO.ai